Bel Air Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bel Air Investment Advisors's BMY Position: Q2 2021 in Review
Bel Air Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2021, selling an estimated $428K and leaving 21,670 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #154.
Bel Air Investment Advisors first reported a position in BMY in Q1 2021 and has held it in 2 quarters since. The position peaked at $1.78M in Q1 2021. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Bel Air Investment Advisors held 21,670 shares of Bristol-Myers Squibb worth $1.45M as of Q2 2021.
- Bel Air Investment Advisors sold 6,569 Bristol-Myers Squibb shares in Q2 2021, an estimated $428K.
- Bristol-Myers Squibb made up 0.04% of Bel Air Investment Advisors's portfolio in Q2 2021, its #154 holding.
- Bel Air Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 2 quarters since.
- Bel Air Investment Advisors's Bristol-Myers Squibb position peaked at $1.78M in Q1 2021.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.